Quantitative cerebral perfusion MRI and CO2 reactivity measurements in patients with symptomatic internal carotid artery occlusion

NeuroImage

Volumn 17, Issue 1, 2002, Pages 469-478

  Van Osch, M J P ^a   Rutgers, D R ^a   Vonken, E P A ^a   Van Huffelen, A C ^b   Klijn, C J M ^c   Bakker, C J G ^a   Van Der Grond, J ^a  

^a Image Science Institute   (Netherlands)

^b Department of Radiology ^*

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Carbon dioxide; Carotid artery occlusion; Cerebrovascular reactivity; Perfusion weighted MRI

Indexed keywords

CARBON DIOXIDE; OXYGEN;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE MONITORING; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN PERFUSION; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DYNAMIC SUSCEPTIBILITY CONTRAST NUCLEAR MAGNETIC RESONANCE IMAGING; FEMALE; GAS ANALYSIS; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MALE; MEDICAL INSTRUMENTATION; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE CEREBRAL PERFUSION NUCLEAR MAGNETIC RESONANCE IMAGING;

EID: 0036743109     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1006/nimg.2002.1214     Document Type: Article

References (35)

1. Apruzzese, A., Silvestrini, M., Floris, R., Vernieri, F., Bozzao, A., Hagberg, G., Caltagirone, C., Masala, S., and Simonetti, G. 2001. Cerebral hemodynamics in asymptomatic patients with internal carotid artery occlusion: A dynamic susceptibility contrast MR and transcranial Doppler study. Am. J. Neuroradiol. 22: 1062-1067.
2. Calamante, F., Gadian, D. G., and Connelly, A. 2000. Delay and dispersion effects in dynamic susceptibility contrast MRI: Simulations using singular value decomposition. Magn. Reson. Med. 44: 466-473.
3. Dahl, A., Russell, D., Nyberg-Hansen, R., Rootwelt, K., and Mowinckel, P. 1994. Simultaneous assessment of vasoreactivity using transcranial Doppler ultrasound and cerebral blood flow in healthy subjects. J. Cereb. Blood Flow Metab. 14: 974-981.
4. Derdeyn, C. P., Grubb, R. L., Jr., and Powers, W. J. 1999. Cerebral hemodynamic impairment: Methods of measurement and association with stroke risk. Neurology 53: 251-259.
5. Ferrari, M., Wilson, D. A., Hanley, D. F., and Traystman, R. J. 1992. Effects of graded hypotension on cerebral blood flow, blood volume, and mean transit time in dogs. Am. J. Physiol 262: H1908-H1914.
6. Fox, A. J. 1993. How to measure carotid stenosis. Radiology 186: 316-318.
7. Gibbs, J. M., Wise, R. J., Leenders, K. L., and Jones, T. 1984. Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet 1: 310-314.
8. Grubb, R. L., Jr., Derdeyn, C. P., Fritsch, S. M., Carpenter, D. A., Yundt, K. D., Videen, T. O., Spitznagel, E. L., and Powers, W. J. 1998. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. J. Am. Med. Assoc. 280: 1055-1060.
9. Gueckel, F., Brix, G., Rempp, K. A., Roether, J., and Georgi, M. 1994. Assessment of cerebral hemodynamics in patients with vascular disorders and brain tumors. Radiology 137: 679-686.
10. Hirano, T., Minematsu, K., Hasegawa, Y., Tanaka, Y., Hayashida, K., and Yamaguchi, T. 1994. Acetazolamide reactivity on 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: Correlation with positron emission tomography parameters. J. Cereb. Blood Flow Metab. 14: 763-770.
11. Kleiser, B., and Widder, B. 1992. Course of carotid artery occlusions with impaired cerebrovascular reactivity. Stroke 23: 171-174.
12. Lin, W., Celik, A., Derdeyn, C., An, H, Lee, Y., Videen, T, Ostergaard, L, and Powers, W. J. 2001. Quantitative measurements of cerebral blood flow in patients with unilateral carotid artery occlusion: A PET and MR study. J. Magn. Reson. Imaging 14: 659-667.
13. Lythgoe, D. J., Ostergaard, L., William, S. C., Cluckie, A., Buxton-Thomas, M., Simmons, A., and Markus, H. S. 2000. Quantitative perfusion imaging in carotid artery stenosis using dynamic susceptibility contrast-enhanced magnetic resonance imaging. Magn. Reson. Imaging 18: 1-11.
14. Markus, H., and Cullinane, M., 2001. Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain 124: 457-467.
15. Muller, M., Voges, M., Piepgras, U., and Schimrigk, K. 1995. Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath-holding. A comparison with acetazolamide as vasodilatory stimulus. Stroke 26: 96-100.
16. Okudaira, Y., Bandoh, K., Arai, H., and Sato, K. 1995. Evaluation of the acetazolamide test. Vasoreactivity and cerebral blood volume. Stroke 26: 1234-1239.
17. Ostergaard, L., Weisskoff, R. M., Chesler, D. A., Gyldensted, C., and Rosen, B. R. 1996. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis. Magn. Reson. Med. 36: 715-725.
18. Perthen, J. E., Calamante, F., Gadian, D. G., and Connelly, A. 2002. Is quantification of bolus tracking MRI reliable without deconvolution? Magn. Reson. Med. 47: 61-67.
19. Powers, W. J. 1991. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann. Neurol. 29: 231-240.
20. Powers, W. J., Press, G. A., and Grubb, R. L., Jr. 1987. The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation. Ann. Intern. Med. 106: 27-35.
21. Rempp, K. A., Brix, G., Wenz, F., Becker, C. R., Gückel, F., and Lorenz, W. J. 1994. Quantification of regional cerebral bloodflow and volume with dynamic susceptibility contrast-enhanced MR Imaging. Radiology 193: 637-641.
22. Ringelstein, E. B., Van Eyck, S., and Mertens, I. 1992. Evaluation of cerebral vasomotor reactivity by various vasodilating stimuli: Comparison of CO2 to acetazolamide. J. Cereb. Blood Flow Metab. 12: 162-168.
23. Schreiber, W. G., Guckel, F., Stritzke, P., Schmiedek, P., Schwartz, A., and Brix, G. 1998. Cerebral blood flow and cerebrovascular reserve capacity: Estimation by dynamic magnetic resonance imaging. J. Cereb. Blood Flow Metab. 18: 1143-1156.
24. Schumann, P., Touzani, O., Young, A. R., Morello, R., Baron, J. C., and MacKenzie, E. T. 1998. Evaluation of the ratio of cerebral blood flow to cerebral blood volume as an index of local cerebral perfusion pressure. Brain 121: 1369-1379.
25. Tomita, M. 1988. Significance of cerebral blood volume. In Cerebral Hyperemia and Ischemia: From the Standpoint of Cerebral Blood Volume. (M. Tomita, T. Sawada, H. Naritomi, W.-D. Heiss, Eds.), pp. 3-31. Elsevier Science, Amsterdam.
26. van Osch, M. J., Vonken, E. J., Bakker, C. J., and Viergever, M. A. 2001. Correcting partial volume artifacts of the arterial input function in quantitative cerebral perfusion MRI. Magn Reson. Med. 45: 477-485.
27. van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J. A., and van Gijn, J. 1988. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19: 604-607.
28. Vernieri, F., Pasqualetti, P., Matteis, M., Passarelli, F., Troisi, E., Rossini, P. M., Caltagirone, C, and Silvestrini, M. 2001. Effect of collateral blood flow and cerebral vasomotor reactivity on the outcome of carotid artery occlusion. Stroke 32: 1552-1558.
29. Vernieri, F., Pasqualetti, P., Passarelli, F., Rossini, P. M., and Silvestrini, M. 1999. Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity. Stroke 30: 593-598.
30. Vonken, E. J., van Osch, M. J., Bakker, C. J., and Viergever, M. A. 1999a. Measurement of cerebral perfusion with dual-echo multi-slice quantitative dynamic susceptibility contrast MRI. J. Magn. Reson. Imaging 10: 109-117.
31. Vonken, E. P. A., Beekman, F. J., Bakker, C. J. G., and Viergever, M. A. 1999b. Maximum likelihood estimation of cerebral blood flow in dynamic susceptibility contrast MRI. Magn. Reson. Med. 41: 343-350.
32. Webster, M. W., Makaroun, M. S., Steed, D. L., Smith, H. A., Johnson, D. W., and Yonas, H. 1995. Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease. J. Vasc. Surg. 21: 338-345.
33. Weisskoff, R. M., Chesler, D., Boxerman, J. L., and Rosen, B. R. 1993. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: Which mean transit time? Magn. Reson. Med. 29: 553-558.
34. Widder, B, Kleiser, B., and Krapf, H. 1994. Course of cerebrovascular reactivity in patients with carotid artery occlusions. Stroke 25: 1963-1967.
35. Yamauchi, H., Fukuyama, H., Nagahama, Y., Nabatame, H., Nakamura, K., Yamamoto, Y. L., Yonekura, Y., Konishi, J., and Kimura, J. 1996. Evidence for misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from PET. J. Neurol. Neurosurg. Psychiatr 61: 18-25.